Factors influencing malignancy and progression in gliomas include the transforming growth factor-β (TGF-β) signaling pathway, which modulates invasiveness, angiogenesis, immune evasion and stem cell maintenance [2, 3]. This evidence concerns the gene TGFB1 and glioma.